Breast cancer is a highly prevalent and molecularly heterogeneous malignancy, where therapeutic resistance and off-target toxicity remain major challenges. Here, we introduce BreastCAR, a multi-target quantitative structure-activity relationship framework trained on ChEMBL bioactivity data covering 53 cancer-relevant t...
Stalin Arulsamy, D. Ramesh, Vanktesh Kumar et al.· Molecular Informatics· 0 citations
Cancer of the prostate is an important issue on a global scale, and therefore the identification of targets to support the development of therapy for this cancer should be a priority, particularly given the rise in cases of advanced prostate cancer and of patients who have developed resistance to the current standard o...
VS-04 was identified as a promising oxadiazole–pyrazole lead with potent antiproliferative activity against prostate cancer cells, which was associated with AR modulation, oxidative stress, cell-cycle perturbation, and apoptotic cell death.
The utility of structure-based virtual screening combined with ADMET prediction as an effective strategy for early-stage lead identification in prostate cancer drug discovery and the improved predicted pharmacokinetic properties suggest that rational modification of heterocyclic scaffolds can yield AR antagonists with...
Vanktesh Kumar, Shivank Sharma, Saminesh Kumar et al.· Current Organocatalysis· 0 citations
Antioxidants are traditionally recognized for their ability to neutralize reactive oxygen species and prevent oxidative deterioration in food systems. However, their biological and technological significance extends beyond radical scavenging, as they undergo oxidation to form reactive derivatives that may exert both be...